je.st
news
Tag: on
Paris attacks - COP21 and the war on terror
2015-11-15 16:29:00| Climate Ark Climate Change & Global Warming Newsfeed
Ecologist: Is it a coincidence that the terrorist outrage in Paris was committed weeks before COP21, the biggest climate conference since 2009? Perhaps, writes Oliver Tickell. But failure to reach a strong climate agreement now looks more probable. And that's an outcome that would suit ISIS - which makes $500m a year from oil sales - together with other oil producers. Yes, it's still about the climate, very much so. But there are also compelling reasons of national and global security to reduce the world's...
Holiday shoppers can get in on the ground floor at Tiffany & Co. on Rodeo Drive
2015-11-15 15:07:40| Jewelry - Topix.net
Here is a computer rendering of the new first floor of Tiffany & Co. on Rodeo Drive in Beverly Hills.
NL Industries (NL) to Release Earnings on Monday
2015-11-15 09:27:34| Chemicals - Topix.net
NL Industries last announced its earnings results on Friday, November 6th. The company reported $0.05 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.11 by $0.06.
Tags: on
release
monday
industries
Merck Announces Presentation of Phase 3 Results of Investigational Elbasvir/Grazoprevir in People with Chronic Hepatitis C Genotypes 1, 4 or 6 Infection Who Inject Drugs and Are on Opioid Agonist Therapy
2015-11-15 01:00:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Results from C-EDGE CO-STAR Presented at The Liver Meeting Show High Sustained Virologic Response After 12 Weeks of Treatment KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of results from the companys Phase 3 C-EDGE CO-STAR clinical trial evaluating the efficacy and safety of the investigational once-daily tablet elbasvir/grazoprevir1 (50mg/100mg) in patients with chronic hepatitis C virus (HCV) genotypes (GT) 1, 4 or 6 infection who inject drugs and are receiving opioid agonist therapy (OAT). Language: English Contact: MerckMedia Contacts:Doris Li, 908-246-5701Sarra Herzog, 201-669-6570orInvestor Contacts:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
NL Industries (NL) to Release Earnings on Monday
2015-11-14 22:11:37| Furniture - Topix.net
NL Industries last announced its earnings results on Friday, November 6th. The company reported $0.05 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.11 by $0.06.
Tags: on
release
monday
industries
Sites : [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265] [266] [267] [268] [269] [270] [271] [272] next »